QQ客服 官方微博 反馈留言

浏览/检索结果: 共11条，第1-10条 帮助 限定条件 专题：武汉大学    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文 作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang 收藏  |  浏览/下载：39/0  |  提交时间：2019/12/05 Cancer Cell Membrane-Coated Nanoparticles for Personalized Therapy in Patient-Derived Xenograft Models 期刊论文 Advanced Functional Materials, 2019 作者:  Rao, Lang;  Yu, Guang-Tao;  Meng, Qian-Fang;  Bu, Lin-Lin;  Tian, Rui 收藏  |  浏览/下载：28/0  |  提交时间：2019/12/05 Environmentally responsive dual-targeting nanotheranostics for overcoming cancer multidrug resistance 期刊论文 Science Bulletin, 2019, 卷号: 64, 期号: 10 作者:  Yang, Caixia;  Pang, Xin;  Chen, Weihai;  Wang, Xiaoyong;  Lin, Gan 收藏  |  浏览/下载：10/0  |  提交时间：2019/12/05 All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文 作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang 收藏  |  浏览/下载：40/0  |  提交时间：2019/12/05 Environmentally responsive dual-targeting nanotheranostics for overcoming cancer multidrug resistance 期刊论文 SCIENCE BULLETIN, 2019, 卷号: 64, 期号: 10 作者:  Yang, Caixia;  Pang, Xin;  Chen, Weihai;  Wang, Xiaoyong;  Lin, Gan 收藏  |  浏览/下载：6/0  |  提交时间：2019/12/05 Cancer chemosensitization  Multidrug resistance  P-glycoprotein  pH-responsive  Magnetic resonance imaging   THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文 作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang 收藏  |  浏览/下载：33/0  |  提交时间：2019/12/05 All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文 作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang 收藏  |  浏览/下载：31/0  |  提交时间：2019/12/05 Integrated analysis of long noncoding RNA associated-competing endogenous RNA as prognostic biomarkers in clear cell renal carcinoma 期刊论文 CANCER SCIENCE, 2018, 卷号: 109, 期号: 10 作者:  Yin, Hang;  Wang, Xiaoyuan;  Zhang, Xue;  Wang, Yan;  Zeng, Yangyang 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05 biomarker  competing endogenous RNA network  long non-coding RNA  renal cell carcinoma  The Cancer Genome Atlas   A search based context- Aware approach for understanding and localizing the fault via weighted call graph 会议论文 作者:  Tu, Jingxuan;  Xie, Xiaoyuan;  Zhou, Yuming;  Xu, Baowen;  Chen, Lin 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05 A search based context- Aware approach for understanding and localizing the fault via weighted call graph 期刊论文 Proceedings - 2016 3rd International Conference on Trustworthy Systems and Their Applications, TSA 2016, 2016 作者:  Tu, Jingxuan;  Xie, Xiaoyuan;  Zhou, Yuming;  Xu, Baowen;  Chen, Lin 收藏  |  浏览/下载：1/0  |  提交时间：2019/12/05